Clinical Trial Update: Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of immunotherapy, chemotherapy, radiotherapy, and surgery for patients with synchronous oligometastatic non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Non-small Cell Lung Cancer, Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING